Use of Lipid-Modifying Agents for the Treatment of Glomerular Diseases is a research paper published in Journal of Personalized Medicine (2021). On theSindex it has a DataRank of 0. It has been cited 11 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: R01DK117599 R01DK104753 R01CA227493
Miami Clinical Translational Science Institute
Grant: U54DK083912 UM1DK100846 U01DK116101 UL1TR000460
American Heart Association
Grant: 18PRE34030042
National Institutes of Health
Grant: 5U01DK116101-08
1-13 ApoL1 Genotypes in Kidney Donors and Long-Term Outcomes in Kidney Transplant Recipients Clinical Center
National Institutes of Health
Grant: 5R01DK104753-02
Cellular Cholesterol and Podocyte function in Diabetic Kidney Disease
National Institutes of Health
Grant: 1R01CA227493-01
(PQ 12) Targeting SMPDL3b to Prevent Radiation-Induced Nephrotoxicity
National Institutes of Health
Grant: 2U54DK083912-06
Nephrotic Syndrome Rare Disease Clinical Research Network
National Institutes of Health
Grant: 1R01DK117599-01
SMPDL3b and podocyte insulin signaling in DKD
National Institutes of Health
Grant: 5UM1DK100846-02
Primary Outcomes in Glomerulonephritis Study (PROGRESS)
National Institutes of Health
Grant: 1UL1TR000460-01A1
Miami Clinical and Translational Science Institute
FWCI
2.02
Citation Percentile
0.9%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals